Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.
Status:
Completed
Trial end date:
2002-05-01
Target enrollment:
Participant gender:
Summary
The study was designed to assess the effect of jaundice on the ability of G17DT to generate
antibodies before and after treatment of biliary obstruction due to advances pancreatic
cancer.